307 related articles for article (PubMed ID: 18208556)
21. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
[TBL] [Abstract][Full Text] [Related]
22. Asp664 cleavage of amyloid precursor protein induces tau phosphorylation by decreasing protein phosphatase 2A activity.
Park SS; Jung HJ; Kim YJ; Park TK; Kim C; Choi H; Mook-Jung IH; Koo EH; Park SA
J Neurochem; 2012 Dec; 123(5):856-65. PubMed ID: 23020770
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
[TBL] [Abstract][Full Text] [Related]
24. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
[TBL] [Abstract][Full Text] [Related]
25. Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta.
Eroglu B; Moskophidis D; Mivechi NF
Mol Cell Biol; 2010 Oct; 30(19):4626-43. PubMed ID: 20679486
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
27. Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells.
Zhou XW; Winblad B; Guan Z; Pei JJ
J Alzheimers Dis; 2009; 17(4):929-37. PubMed ID: 19542610
[TBL] [Abstract][Full Text] [Related]
28. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
29. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
[TBL] [Abstract][Full Text] [Related]
30. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
[TBL] [Abstract][Full Text] [Related]
31. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.
van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13888-93. PubMed ID: 20643941
[TBL] [Abstract][Full Text] [Related]
32. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1.
Boutajangout A; Leroy K; Touchet N; Authelet M; Blanchard V; Tremp G; Pradier L; Brion JP
Neurosci Lett; 2002 Jan; 318(1):29-33. PubMed ID: 11786218
[TBL] [Abstract][Full Text] [Related]
33. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
35. G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.
Guimarães TR; Swanson E; Kofler J; Thathiah A
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):942-957. PubMed ID: 34164834
[TBL] [Abstract][Full Text] [Related]
36. Role of protein phosphatase 2A in Alzheimer's disease.
Rudrabhatla P; Pant HC
Curr Alzheimer Res; 2011 Sep; 8(6):623-32. PubMed ID: 21605044
[TBL] [Abstract][Full Text] [Related]
37. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
38. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
Mold MJ; O'Farrell A; Morris B; Exley C
J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex.
Schweiger S; Matthes F; Posey K; Kickstein E; Weber S; Hettich MM; Pfurtscheller S; Ehninger D; Schneider R; Krauß S
Sci Rep; 2017 Oct; 7(1):13753. PubMed ID: 29062069
[TBL] [Abstract][Full Text] [Related]
40. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
